WYDE
    Impact startupHealthSeries A

    Superpower

    Superpower is a startup that offers personalized, preventative health care in the United States, with lab testing and AI-generated health overviews.

    Raised in the rounds listed
    $34 million
    Founders
    Kevin Unkrich, Max Marchione, Jacob Peters
    Founded
    2023

    Who it reaches

    People in the United States who want personalized, preventative and longevity-focused medicine, with twice-yearly lab testing and a personal health plan.

    Superpower funding rounds

    DateRoundAmount
    Apr 23, 2025Series A$30 million
    May 21, 2024Pre-seed$4 million

    Key facts

    Founded
    2023, in San Franciscosource
    Series A
    $30 million, reported April 2025source
    Pre-seed
    $4 million, led by Susa Ventures, May 2024source
    Chief executive
    Jacob Peters, as of May 2024source
    Peptide sales
    Selling legally available peptides and subscription biomarker testing to members as of January 2024source
    Valuation reported
    more than $300 million, April 2025source
    App price (US)
    US$499 a yearsource
    Peptide launch
    Opened pre-orders on October 30, 2026 for BPC-157 and TB-500 at $149 a month and MOTS-c at $199 a month, with a target ship date of late Novembersource
    Peptide status
    Its page says compounded BPC-157 is not FDA-approved and that the HHS policy it relies on is not FDA approvalsource

    WYDE coverage of Superpower

    WYDE Newsroom has published 3 articles about Superpower, from Oct 27, 2026 to Oct 31, 2026. Superpower is the subject of 3 stories. The most recent is Last Day to Apply: The $1 Million Creator Fund Closes Tonight.

    WYDE Weekly

    Last Day to Apply: The $1 Million Creator Fund Closes Tonight

    WYDE Weekly: EAT's $1 million clipping fund closes tonight at 11:59 p.m. Pacific. Plus 33 countries on stockpiling food, WFP's Gaza cuts, a prank that became a $605,350 GoFundMe, $200 million for Boston Children's and the $6.3 billion Binance hack.

    Oct 31, 2026 · 8 min read · Subject of the story

    Healthcare

    Superpower Opens $149-a-Month BPC-157 Pre-Orders Two Days After HHS Eased Peptide Enforcement

    Superpower will charge $149 a month for compounded BPC-157 and TB-500 and $199 for MOTS-c, shipping in late November. FDA's drug center recommended against listing all three, and the policy allowing the sales is not FDA approval.

    Oct 30, 2026 · 4 min read · Subject of the story

    Healthcare

    Superpower's 152-Peptide Library Includes BPC-157, Which FDA Proposed Keeping Off the 503A Bulks List

    Superpower announced its 152-peptide library on X on October 26, 2026. Its BPC-157 entry notes a July advisory vote in favor of compounding, while FDA's own briefing proposed against listing the peptide.

    Oct 27, 2026 · 4 min read · Subject of the story

    Reported alongside Superpower

    Sources

    Track the institutions that move money.

    Data-driven coverage, every week.